CoreMedusa.com

About CoreMedusa.com

Coremed, Inc. is a privately funded biotech company founded in 1994. Coremed has developed an inhalable form of insulin based on a proprietary new platform for drug delivery. Our first product "Alveair", boasts close to 100% bio-availability, no respiratory side-effects during preliminary human trials, and oral delivery rendering injections unnecessary.



Retrieved from "http://aboutus.com/index.php?title=CoreMedusa.com&oldid=25283217"